Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ABCD1P3 is a human pseudogene corresponding in sequence to ABCD1, ATP binding cassette subfamily D member 1. Pseudogenes like ABCD1P3 arise from gene duplication or retrotransposition events and typically carry mutations that prevent expression of a functional protein product[4][6]. ABCD1P3 is annotated in gene databases as non-protein coding, belonging to the ABC transporter superfamily by sequence homology but lacking any documented function, involvement in disease, or role as a therapeutic target[5]. While some ABC family pseudogenes can be transcriptionally active and may play subtle regulatory RNA roles[2], there is no evidence that ABCD1P3 itself encodes a protein, interacts with drugs, or serves as a biomarker in any clinical context[5].
None applicable for ABCD1P3, as there is no protein product to target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP binding cassette subfamily D member 1 pseudogene 3 (ABCD1P3).